Patents by Inventor Jianjing JIA

Jianjing JIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Complex of angiotensin receptor antagonist and neutral endopeptidase inhibitor
    Patent number: 10537555
    Abstract: Provided a complex of formula is [3-((1S, 3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl) propionate-(S)-3?-methyl-2?-(pentanoyl {2?-(tetrazol-5-ylate) biphenyl-4?-ylmethyl}amino) butyrate]6.XCa2+.YNa+.ZH2O, wherein X=1-3, Y=12-16, Z=9-18, and 2X+Y=18, and represented by formula (I). Also disclosed are the method of preparing the complex and the method of treating chronic heart disease using a medicament comprising the complex.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: January 21, 2020
    Assignee: Chengdu Easton Biopharmaceuticals Co., Ltd
    Inventors: Ying Wang, Long Huang, Yongzhe Xiang, Guodong Cen, Jianguo Li, Jianjing Jia, Qiangqiang Liu, Yang Liu, Haitao Yang, Qing Dong
  • COMPLEX OF ANGIOTENSIN RECEPTOR ANTAGONIST AND NEUTRAL ENDOPEPTIDASE INHIBITOR
    Publication number: 20180318259
    Abstract: Provided a complex of formula is [3-((1S, 3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl) propionate-(S)-3?-methyl-2?-(pentanoyl {2?-(tetrazol-5-ylate) biphenyl-4?-ylmethyl}amino) butyrate]6.XCa2+.YNa+.ZH2O, wherein X=1-3, Y=12-16, Z=9-18, and 2X+Y=18, and represented by formula (I). Also disclosed are the method of preparing the complex and the method of treating chronic heart disease using a medicament comprising the complex.
    Type: Application
    Filed: September 1, 2016
    Publication date: November 8, 2018
    Inventors: Ying WANG, Long HUANG, Yongzhe XIANG, Guodong CEN, Jianguo LI, Jianjing JIA, Qiangqiang LIU, Yang LIU, Haitao YANG, Qing DONG